What does IsoRay Inc do?
About IsoRay, Inc. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds.
Why did IsoRay go up?
Shares of Isoray (NYSEMKT:ISR) gained more than 200% in pre-market trading this morning after the internal radiation therapy developer announced it had received U.S. Food and Drug Administration clearance for the use of its brachytherapy seeds along with MRI markers by C4 Therapeutics (NASDAQ:CCCC) to treat prostate …
Should I buy ISR stock?
There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Isoray stock.
How old is IsoRay?
2004
Isoray is a registered manufacturer with the FDA and holds multiple 510(k) clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu….IsoRay.
| Type | Public |
|---|---|
| Founded | 2004 |
| Headquarters | Richland, Washington |
| Website | http://www.isoray.com |
Will ISR stock go up?
The IsoRay, Inc stock price gained 0.73% on the last trading day (Tuesday, 25th Jan 2022), rising from $0.34 to $0.35….Predicted Opening Price for IsoRay, Inc of Wednesday, January 26, 2022.
| Fair opening price January 26, 2022 | Current price |
|---|---|
| $0.35 | $0.35 (Undervalued) |
Will IsoRay go up?
Will Isoray stock price grow / rise / go up? Yes. The ISR stock price can go up from 0.366 USD to 0.555 USD in one year.
Is BNGO a good stock?
Based on his analysis, DeGeeter rates BNGO stock as “outperform” with a $14 value. Other analysts are also bullish on the company. Those tracked by the Wall Street Journal have BNGO rated as a consensus “buy” with an average $12 price target.
Can brachytherapy be repeated?
The procedure may be repeated a few times, depending on your specific treatment plan. The radioactive source is removed from your body after HDR brachytherapy, so you won’t need any special precautions to avoid close contact with other people.
Is BNGO a pump and dump?
BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.
Does ARKG hold BNGO?
More than three months of persistent stock promotion along the lines of “today is finally the day!” ARK Genomic Revolution ETF (NYSEARCA:ARKG) will show more than just mouthpiece interest, BNGO remains a goose egg for the fund through the end of the first quarter.
Does Isoray (ISR) stock deliver earnings and revenue surprises in 2021?
IsoRay (ISR) delivered earnings and revenue surprises of 0.00% and 6.56%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
What is Isoray’s core product?
Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. Will IsoRay (ISR) Report Negative Earnings Next Week?
Who holds Isoray’s stock?
Only 2.42% of the stock of Isoray is held by insiders. Only 12.18% of the stock of Isoray is held by institutions. Earnings for Isoray are expected to grow in the coming year, from ($0.04) to ($0.02) per share.
What are analysts’price targets for Isoray’s stock?
4 brokerages have issued 12-month price targets for Isoray’s stock. Their forecasts range from $1.00 to $3.00. On average, they expect Isoray’s stock price to reach $2.03 in the next year. This suggests a possible upside of 186.0% from the stock’s current price.